Report for Londong W

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (14)

Title : Modern approach to the evaluation of combined effects of single-dose trials and clinical time-course studies, exemplified by combinations of pirenzepine and H2-receptor antagonists - Poch_1993_Int.J.Clin.Pharmacol.Ther.Toxicol_31_483
Author(s) : Poch G , Londong W
Ref : Int J Clinical Pharmacology & Therapeutics Toxicol , 31 :483 , 1993
Abstract : Poch_1993_Int.J.Clin.Pharmacol.Ther.Toxicol_31_483
ESTHER : Poch_1993_Int.J.Clin.Pharmacol.Ther.Toxicol_31_483
PubMedSearch : Poch_1993_Int.J.Clin.Pharmacol.Ther.Toxicol_31_483
PubMedID: 8262686

Title : The effect of combined therapy with ranitidine and pirenzepine in the treatment of reflux oesophagitis - Londong_1992_Aliment.Pharmacol.Ther_6_609
Author(s) : Londong W , Phillips J , Johnson NJ , Wood JR
Ref : Aliment Pharmacol Ther , 6 :609 , 1992
Abstract : Londong_1992_Aliment.Pharmacol.Ther_6_609
ESTHER : Londong_1992_Aliment.Pharmacol.Ther_6_609
PubMedSearch : Londong_1992_Aliment.Pharmacol.Ther_6_609
PubMedID: 1420752

Title : Pharmacokinetic and pharmacodynamic studies in man simulating acute and chronic treatment with oral pirenzepine - Londong_1989_Eur.J.Clin.Pharmacol_36_369
Author(s) : Londong W , Londong V , Federle C , Tanswell P , Voderholzer U
Ref : European Journal of Clinical Pharmacology , 36 :369 , 1989
Abstract : Londong_1989_Eur.J.Clin.Pharmacol_36_369
ESTHER : Londong_1989_Eur.J.Clin.Pharmacol_36_369
PubMedSearch : Londong_1989_Eur.J.Clin.Pharmacol_36_369
PubMedID: 2737229

Title : Telenzepine is at least 25 times more potent than pirenzepine--a dose response and comparative secretory study in man - Londong_1987_Gut_28_888
Author(s) : Londong W , Londong V , Meierl A , Voderholzer U
Ref : Gut , 28 :888 , 1987
Abstract : Londong_1987_Gut_28_888
ESTHER : Londong_1987_Gut_28_888
PubMedSearch : Londong_1987_Gut_28_888
PubMedID: 3653758

Title : Poster: Telenzepine is more than 25-times more potent than pirenzepine a dose response and comparative secretory study in man -
Author(s) : Voderholzer U , Londong V , Londong W , Meierl A
Ref : Trends in Pharmacological Sciences , Suppl :89 , 1986
PubMedID:

Title : Poster: Interactions of pirenzepine and ranitidine in man - pharmacodynamic secretory studies -
Author(s) : Londong W , Bozler G , Eberl H , Gugler R , Londong V , Poch G
Ref : Trends in Pharmacological Sciences , Suppl :89 , 1986
PubMedID:

Title : Anti-ulcer drugs in antisecretory doses for cytoprotection in arthritic patients? - Londong_1986_Klin.Wochenschr_64 Suppl 7_32
Author(s) : Londong W
Ref : Klin Wochenschr , 64 Suppl 7 :32 , 1986
Abstract : Londong_1986_Klin.Wochenschr_64 Suppl 7_32
ESTHER : Londong_1986_Klin.Wochenschr_64 Suppl 7_32
PubMedSearch : Londong_1986_Klin.Wochenschr_64 Suppl 7_32
PubMedID: 2882050

Title : Present status and future perspectives of muscarinic receptor antagonists - Londong_1986_Scand.J.Gastroenterol.Suppl_125_55
Author(s) : Londong W
Ref : Scand J Gastroenterol Suppl , 125 :55 , 1986
Abstract : Londong_1986_Scand.J.Gastroenterol.Suppl_125_55
ESTHER : Londong_1986_Scand.J.Gastroenterol.Suppl_125_55
PubMedSearch : Londong_1986_Scand.J.Gastroenterol.Suppl_125_55
PubMedID: 2881347

Title : Simple approach to assess potentiated drug combinations in clinical trials: studies with pirenzepine plus H2-receptor antagonists - Poch_1985_Int.J.Clin.Pharmacol.Ther.Toxicol_23_283
Author(s) : Poch G , Londong W
Ref : Int J Clinical Pharmacology & Therapeutics Toxicol , 23 :283 , 1985
Abstract : Poch_1985_Int.J.Clin.Pharmacol.Ther.Toxicol_23_283
ESTHER : Poch_1985_Int.J.Clin.Pharmacol.Ther.Toxicol_23_283
PubMedSearch : Poch_1985_Int.J.Clin.Pharmacol.Ther.Toxicol_23_283
PubMedID: 2862111

Title : Classification of antimuscarinic substances. Round table discussion -
Author(s) : Sewing KF , Londong W , Stockbrugger RW , Jaup BH , Stockton J , Birdsall NJ , Hammer R , Koelle G , Heathcote BW , Dotevall G
Ref : Scand J Gastroenterol Suppl , 72 :265 , 1982
PubMedID: 6127795

Title : Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine - Londong_1981_Gut_22_542
Author(s) : Londong W , Londong V , Ruthe C , Weizert P
Ref : Gut , 22 :542 , 1981
Abstract : Londong_1981_Gut_22_542
ESTHER : Londong_1981_Gut_22_542
PubMedSearch : Londong_1981_Gut_22_542
PubMedID: 6114900

Title : [Effectiveness of cimetidine, pirenzepine and synthetic secretin on stimulated gastric acid secretion] - Londong_1980_Z.Gastroenterol_18_306
Author(s) : Londong W , Londong V , Prechtl R , Schwanner A
Ref : Z Gastroenterol , 18 :306 , 1980
Abstract : Londong_1980_Z.Gastroenterol_18_306
ESTHER : Londong_1980_Z.Gastroenterol_18_306
PubMedSearch : Londong_1980_Z.Gastroenterol_18_306
PubMedID: 6893378

Title : Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man - Londong_1980_Scand.J.Gastroenterol.Suppl_66_103
Author(s) : Londong W , Londong V , Prechtl R , Weber T , von Werder K
Ref : Scand J Gastroenterol Suppl , 66 :103 , 1980
Abstract : Londong_1980_Scand.J.Gastroenterol.Suppl_66_103
ESTHER : Londong_1980_Scand.J.Gastroenterol.Suppl_66_103
PubMedSearch : Londong_1980_Scand.J.Gastroenterol.Suppl_66_103
PubMedID: 6941373

Title : Nicotine and arteriosclerosis. An experimental contribution to the influence of nicotine on fat metabolism -
Author(s) : Schievelbein H , Londong V , Londong W , Grumbach H , Remplik V
Ref : Z Klin Chem Klin Biochem , 8 :190 , 1970
PubMedID: 5470739